AVTX
NASDAQ · Biotechnology
Avalo Therapeutics Inc
$15.25
+0.17 (+1.13%)
AVTX News2 articles
Avalo Therapeutics Soars 34% on $375M Offering Following Positive Phase 2 HS Data
Avalo Therapeutics shares surged 34% after pricing a $375M public offering, following positive Phase 2 results for abdakibart in hidradenitis suppurativa. The company aims to fund Phase 3 development.
Avalon Technologies Slips After Record Rally; Nomura's Target Faces Scrutiny
Avalon Technologies shares eased 1.1% on Tuesday after a record-setting rally. Nomura's bullish target assumes robust JV returns, but key financial details remain undisclosed.